ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor ModelsCherrie K. Donawho, David J. Frost, Theodore L. DeWeese et al.|Clinical Cancer Research|2007Cited by 770
CCR2 chemokine receptor signaling mediates pain in experimental osteoarthritisRachel E. Miller, Anne‐Marie Malfait, Phuong B. Tran et al.|Proceedings of the National Academy of Sciences|2012Cited by 289